Incidence of mesothelioma in young people and causal exposure to asbestos in the Italian national mesothelioma registry (ReNaM).


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 02 05 2023
accepted: 29 08 2023
medline: 1 11 2023
pubmed: 15 10 2023
entrez: 9 10 2023
Statut: ppublish

Résumé

The epidemiological surveillance of mesothelioma incidence is a crucial key for investigating the occupational and environmental sources of asbestos exposure. The median age at diagnosis is generally high, according to the long latency of the disease. The purposes of this study are to analyse the incidence of mesothelioma in young people and to evaluate the modalities of asbestos exposure. Incident malignant mesothelioma (MM) cases in the period 1993-2018 were retrieved from Italian national mesothelioma registry and analysed for gender, incidence period, morphology and exposure. Age-standardised rates have been calculated and the multiple correspondence analysis has been performed. The association between age and asbestos exposure has been tested by χ From 1993 to 2018, 30 828 incident MM cases have been collected and 1278 (4.1%) presented diagnosis at early age (≤50 years). There is a substantial association between age at diagnosis and the type of asbestos exposure and a significantly lower frequency of cases with occupational exposure to asbestos (497 cases vs 701 expected) in young people has been documented. Paraoccupational and environmental exposure to asbestos have been found more frequent in young MM cases (85 and 93 observed cases vs 52 and 44 expected cases, respectively). Mesothelioma incidence surveillance at population level and the anamnestic individual research of asbestos exposure is a fundamental tool for monitoring asbestos exposure health effects, supporting the exposure risks prevention policies. Clusters of mesothelioma incident cases in young people are a significant signal of a potential non-occupational exposure to asbestos.

Identifiants

pubmed: 37813485
pii: oemed-2023-108983
doi: 10.1136/oemed-2023-108983
doi:

Substances chimiques

Asbestos 1332-21-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-609

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CM and DCo reported that they have served as expert witnesses in court trials on asbestos-related diseases.

Auteurs

Alessandro Marinaccio (A)

Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Italian Workers' Compensation Authority (INAIL), Rome, Italy a.marinaccio@inail.it.

Davide Di Marzio (D)

Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Italian Workers' Compensation Authority (INAIL), Rome, Italy.

Carolina Mensi (C)

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Dario Consonni (D)

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Carmela Gioscia (C)

Valle d'Aosta Health Local Unit, Valle d'Aosta Region, Aosta, Italy.

Enrica Migliore (E)

COR Piemonte, Unit of Cancer Epidemiology, University of Turin and CPO-Piemonte, Torino, Italy.

Carlo Genova (C)

Internal Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Roberta Rossetto Giaccherino (R)

Internal Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Silvia Eccher (S)

Provincial Unit of Health Hygiene and Occupational Medicine, COR Province of Trento- APSS, Trento, Italy.

Stefano Murano (S)

Occupational Medicine Unit, COR PA Bolzano, Bolzano, Italy.

Vera Comiati (V)

COR Veneto, Azienda Zero, Veneto Region, Padova, Italy.

Veronica Casotto (V)

COR Veneto, Azienda Zero, Veneto Region, Padova, Italy.

Corrado Negro (C)

COR Friuli Venezia Giulia, Unit of Occupational Medicine, University of Trieste, Trieste Hospital, Trieste, Italy.

Lucia Mangone (L)

COR Emilia-Romagna, Reggio Emilia, Italy.

Lucia Miligi (L)

ISPRO, COR Toscana, Florence, Italy.

Sara Piro (S)

ISPRO, COR Toscana, Florence, Italy.

Alessia Angelini (A)

ISPRO, COR Toscana, Florence, Italy.

Iolanda Grappasonni (I)

COR Marche, University of Camerino, School of Pharmacy, Camerino, Italy.

Gabriella Madeo (G)

COR Umbria, Umbria Region, Perugia, Italy.

Ilaria Cozzi (I)

COR Lazio, Department of Epidemiology, Lazio Regional Health Service, ASL Roma1, Rome, Italy.

Laura Ancona (L)

COR Lazio, Department of Epidemiology, Lazio Regional Health Service, ASL Roma1, Rome, Italy.

Tommaso Staniscia (T)

COR Abruzzo, Abruzzo Regional Health Agency (ASR), Pescara, Italy.

Francesco Carrozza (F)

COR Molise, Oncology Unit, Cardarelli Hospital, Campobasso, Italy.

Domenica Cavone (D)

Section Occupational Medicine, Interdisciplinary Department of Medicine, COR Puglia, University of Bari Aldo Moro, Bari, Italy.

Luigi Vimercati (L)

Section Occupational Medicine, Interdisciplinary Department of Medicine, COR Puglia, University of Bari Aldo Moro, Bari, Italy.

Michele Labianca (M)

COR Basilicata, Epidemiologic Regional Center, Basilicata Region, Potenza, Italy.

Federico Tallarigo (F)

COR Calabria, Public Health Unit, Regione Calabria, Crotone, Italy.

Giuseppe Cascone (G)

Public Health Agency Ragusa (ASP), COR Mesoteliomi della Sicilia, Ragusa, Italy.

Massimo Melis (M)

COR Sardegna, Sardegna Region, Cagliari, Italy.

Michela Bonafede (M)

Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Italian Workers' Compensation Authority (INAIL), Rome, Italy.

Alberto Scarselli (A)

Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Italian Workers' Compensation Authority (INAIL), Rome, Italy.

Alessandra Binazzi (A)

Occupational and Environmental Medicine, Epidemiology and Hygiene Department, Italian Workers' Compensation Authority (INAIL), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH